Drug Shortage Report for ACTEMRA
Report ID | 144440 |
Drug Identification Number | 02350114 |
Brand name | ACTEMRA |
Common or Proper name | ACTEMRA |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TOCILIZUMAB |
Strength(s) | 400MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 400MG/20ML 1VIAL |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-07-15 |
Actual start date | |
Estimated end date | 2022-07-30 |
Actual end date | 2022-06-22 |
Shortage status | Avoided shortage |
Updated date | 2022-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v27 | 2022-07-20 | English | Compare |
v26 | 2022-06-23 | French | Compare |
v25 | 2022-06-23 | English | Compare |
v24 | 2022-06-16 | French | Compare |
v23 | 2022-06-16 | English | Compare |
v22 | 2022-05-31 | French | Compare |
v21 | 2022-05-31 | English | Compare |
v20 | 2022-05-31 | English | Compare |
v19 | 2022-05-03 | French | Compare |
v18 | 2022-05-03 | English | Compare |
v17 | 2022-05-01 | English | Compare |
v16 | 2022-04-12 | French | Compare |
v15 | 2022-04-12 | English | Compare |
v14 | 2022-03-31 | French | Compare |
v13 | 2022-03-31 | English | Compare |
v12 | 2022-02-17 | French | Compare |
v11 | 2022-02-17 | English | Compare |
v10 | 2022-01-13 | English | Compare |
v9 | 2022-01-07 | French | Compare |
v8 | 2022-01-07 | English | Compare |